About this Presentation
Lack of sexual desire and sexual problems relating to ageing in women are common and multifactorial. Perimenopause may be associated with significant symptoms requiring treatment. Dyspareunia is under-identified and topical oestrogen for this and atrophic symptoms is under-utilised after menopause. The only evidence-based indication in Australia for testosterone therapy in women is Hypoactive Sexual Desire Dysfunction and not for any other symptom, clinical condition or disease prevention.
About the Expert
Prof Susan Davis AO
Prof Susan Davis AO is an NHMRC Senior Principal Research Fellow, Director, Monash University Women’s Health Research Program, Consultant Endocrinologist and Head, Specialist Women’s Health Clinic, Alfred Hospital Melbourne and Consultant at Cabrini Medical Centre. She is a Fellow of the Australian Academy of Health and Medical Sciences.
She has over 435 peer-reviewed publications and has received numerous national and international prestigious research awards. She was appointed an Officer of the Order of Australia for distinguished service to medicine, to women's health as a clinical endocrinologist and researcher, and to medical education.
